Bullboard Post History

by jimsenior

Order by:

T.ONC	RE:No shares were margined in the US and only few in Canada @Noteable. You will notice in my comment to Sundaylady that I omitted the... March 9, 2023
T.ONC	RE:Short Attack - Strategic Review @Sundaylady. I agree they need more help on the strategy side, and suggested... March 9, 2023
T.ONC	RE:No Poison pill for ONCY? @westcoast1000. I am reasonably certain there is something in place. I am not... March 8, 2023
T.ONC	RE:Low Share Price Valuation, why? OUTWIT OUTPLAY OUTLAST March 8, 2023
T.ONC	RE:RE:RE:RE:And That's Not All @inthno. Advanced cancers can be locally advanced or metastatic. Locally... March 5, 2023
T.ONC	RE:RE:RE:RE:And That's Not All @inthno. Agreed. I was only guessing, and your take is more likely. I just... March 4, 2023
T.ONC	RE:RE:And That's Not All to myself. A better question. If the EMA or FDA grant Accelerated Approval... March 4, 2023
T.ONC	RE:And That's Not All Cohort 1 of GOBLET was for first-line metastatic PDAC patients. On... March 4, 2023
T.ONC	RE:And That's Not All @proboscises. Thank you for your fine read of the call. I only read the... March 3, 2023
T.ONC	RE:Excellent Article Courtesy of jimsenior @Proboscises. I think Houra Loghmani will give a much broader talk than the... February 21, 2023
T.ONC	RE:Pela + CAR-T Presentation at the CAR-TRC Summit on Feb. 22nd @probo. Search - Re-purposing Oncolytic Virotherapy to Reinvigorate CAR T... February 21, 2023
T.ONC	RE:RE:RE:RE:Phase 1 Colorectal Cancer demonstrated 93% clinical benefit @buck. Thank you so much. You prompted me to look up something that clarifies... February 18, 2023
T.ONC	RE:RE:RE:Matt Expects Pela to Work Against Colorectal Cancer @myself. Cohort 3 of GOBLET mCRC is an intriguing combo of pela, Lonsurf, and... February 18, 2023
T.ONC	RE:RE:Matt Expects Pela to Work Against Colorectal Cancer to jim & probo. Cohort 3 of GOBLET includes LONSURF aka TAS-102; said... February 17, 2023
T.ONC	RE:Matt Expects Pela to Work Against Colorectal Cancer @proboscises. You may know the following. In Japan 10 per cent of men and 8... February 17, 2023
T.ONC	RE:Matt Expects Pela to Work Against Colorectal Cancer @Proboscises. Yes. Added a few today. CRC may well influence a final result... February 17, 2023
T.ONC	RE:RE:RE:RE:The Business of Biotech interview... @buck. You are the master of not helping. Why not contribute and tell us how... February 14, 2023
T.ONC	RE:RE:RE:RE:The Business of Biotech interview... @jim. Spelling correction. play a roll should be play a role. I want this... February 14, 2023
T.ONC	RE:RE:RE:The Business of Biotech interview... @fox. Yes. I should have read your first post more carefully. It is useful... February 14, 2023
T.ONC	RE:The Business of Biotech interview... @fox. First, let me say I liked the talk. I am not sure you heard MC exactly... February 14, 2023

Become a member today, It's free!

Bullboard Post History

by jimsenior

RE:No shares were margined in the US and only few in Canada

RE:Short Attack - Strategic Review

RE:No Poison pill for ONCY?

RE:Low Share Price Valuation, why?

RE:RE:RE:RE:And That's Not All

RE:RE:RE:RE:And That's Not All

RE:RE:And That's Not All

RE:And That's Not All

RE:And That's Not All

RE:Excellent Article Courtesy of jimsenior

RE:Pela + CAR-T Presentation at the CAR-TRC Summit on Feb. 22nd

RE:RE:RE:RE:Phase 1 Colorectal Cancer demonstrated 93% clinical benefit

RE:RE:RE:Matt Expects Pela to Work Against Colorectal Cancer

RE:RE:Matt Expects Pela to Work Against Colorectal Cancer

RE:Matt Expects Pela to Work Against Colorectal Cancer

RE:Matt Expects Pela to Work Against Colorectal Cancer

RE:RE:RE:RE:The Business of Biotech interview...

RE:RE:RE:RE:The Business of Biotech interview...

RE:RE:RE:The Business of Biotech interview...

RE:The Business of Biotech interview...

Featured Company

Prospera Energy Inc. V.PEI

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by jimsenior

Featured Company